Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Future Horizons: Next-Gen Developments Beyond their current offerings, semaglutide and dulaglutide are the subjects of ongoing research assessing long-term benefits and potential in multi-faceted diabetes care plans
Trulicity (dulaglutide ) a once-weekly GLP-1 injection for type 2 diabetes, with approved use for cardiovascular risk reduction in adults with established heart disease
Suppose one option costs a fifth more per month and delivers roughly half again as much average weight reduction
You'll take your medication home with you
One notable study is the SUSTAIN 6 trial, which involved over 3,000 participants with type 2 diabetes and established cardiovascular disease
By mapping your unique peptide-pathway genetics, PlexusDx identifies whether a single GLP-1 approach, dual GLP-1/GIP therapy (like GLP-Squared), or targeted oral formulations best match your metabolic biology
